Pacific Biosciences
PACB
PACB
228 hedge funds and large institutions have $332M invested in Pacific Biosciences in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $2.38M | Put options by funds: $3M
49% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 71
67% less capital invested
Capital invested by funds: $1.01B → $332M (-$673M)
Holders
228
Holding in Top 10
3
Calls
$2.38M
Puts
$3M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$11.7M | |
| 3 | +$4.47M | |
| 4 |
Goldman Sachs
New York
|
+$3.59M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$3.43M |
Top Sellers
| 1 | -$31.5M | |
| 2 | -$26.3M | |
| 3 | -$24.9M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$17.2M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$11.7M |